Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NPB-01 in Guillain-Barré Syndrome
NCT02221271Phase 3Completed
- Sponsor
- Nihon Pharmaceutical
- Start
- Oct 2014
- Primary completion
- Aug 2015
- Modality
- Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of NPB-01-ME in Guillain-Barré syndrome (GBS), sponsored by Nihon Pharmaceutical. Started Oct 2014; status: completed.
02
Drugs
NPB-01-ME
03
Conditions
Guillain-Barré syndrome (GBS)
Beyond the preview
Go deeper on NCT02221271.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02221271.